Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

February 1, 2027

Study Completion Date

July 1, 2027

Conditions
Diabetic Neuropathies
Interventions
DRUG

Fish Oil Concentrate, 1000 Mg Oral Capsule

Oral capsules, 2 grams or 4 grams per day.

DRUG

Salsalate Oral Tablet

Oral tablets, 1.5 gram or 3.0 gram per day.

Trial Locations (2)

52241

RECRUITING

University of Iowa, Iowa City

97239

RECRUITING

Oregon Health Science University, Portland

All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Oregon Health and Science University

OTHER

lead

University of Iowa

OTHER